ABSTRACT Normal human T cells proliferate vigorously when stimulated with autologous non-T cells. This autologous mixed lymphocyte reaction (MLR) between T and non-T cells was defective in patients with active systemic lupus erythematosus (SLE) In contrast, T cells and non-T cells from active SLE patients behaved normally as responding and stimulating cells, respectively, in the allogeneic MLR. Systemic lupus erythematosus (SLE) is a complex multisystem autoimmune disease. One of its most prominent features is the presence of a wide variety of autoantibodies in the serum. In addition, several T cell defects have been described in patients with active SLE. It has been postulated that the excessive production of autoantibodies is due to some abnormality in B cell regulation by T cells (1, 2). More specifically, evidence has been presented to suggest a relative lack of suppressor T cell function in such patients (3-5).
Systemic lupus erythematosus (SLE) is a complex multisystem autoimmune disease. One of its most prominent features is the presence of a wide variety of autoantibodies in the serum. In addition, several T cell defects have been described in patients with active SLE. It has been postulated that the excessive production of autoantibodies is due to some abnormality in B cell regulation by T cells (1, 2) . More specifically, evidence has been presented to suggest a relative lack of suppressor T cell function in such patients (3) (4) (5) .
In the course of our studies of suppressor T cell function in patients with SLE (5), we made the unexpected observation that, when lymphocytes from patients with SLE were used, the autologous mixed lymphocyte reaction (MLR) failed to occur.
That is, whereas T cells from normal individuals proliferate vigorously in response to autologous non-T cells, T cells from SLE patients failed to proliferate normally in response to autologous non-T cells. In these studies we have investigated the reason for this defect in patients with SLE. Because it has been recently proposed that "autologous MLR reflect a mechanism by which T lymphocytes regulate lymphocyte function" (6) , the absence of such a reaction in the lymphocytes of patients with SLE is particularly provocative.
MATERIALS AND METHODS
Patients. All of the 33 patients studied satisfied the prelim- 
RESULTS
Autologous MLR with Normal and SLE Lymphocytes. The lymphocytes of 38 normal individuals were studied in the autologous MLR. Purified T cells were used as responding cells and were stimulated to proliferate by autologous non-T cells. All normals responded vigorously (mean response, 9500 cpm; range 5100-27,500 cpm) (Fig. 1) . No significant difference in the response was noted between males and females (data not shown). The 33 patients with SLE were divided on the basis of clinical disease activity into an "active" SLE group and an "inactive" disease group. Fifteen patients with inactive SLE responded with a mean A cpm of 5000 (range, 1600-11,400 cpm). This mean response was significantly different from that of the normal individuals (P < 0.001); however, in 9 of these 15 (10) , for the following reasons. First, despite the fact that 10 inactive patients had been treated with low doses of corticosteroids, 7 of them showed normal autologous MLR; second, in 4 active patients who had not received any medications, their autologous MLR was profoundly impaired. Third, in two active patients reinvestigated after corticosteroid-induced remission, the autologous MLR went from abnormal (400 and 1300 A cpm) to normal (5900 and 7000 A cpm). Taken together, these data provide strong evidence that the failure of autologous MLR in SLE patients is attributable to the disease itself.
In (Fig. 2) . This was true regardless of the source of the stimulating non-T cells used. That is, non-T cells from normals and those from patients with either inactive or active SLE served adequately as stimulating cells. Thus, when unfrac- With normal individuals, Fc+ T cells as well as Fc-T cells responded well in both autologous and allogeneic MLR (Figs.  3 and 4 ). Selected patients with inactive SLE whose unfractionated T cells responded to a normal or almost normal degree in autologous MLR were then tested for the responding capacity of their fractionated T cells. The Fc-T cell fractions obtained from these patients responded well in both autologous and allogeneic MLR. In contrast, only minimal responses were obtained with Fc+ T cell fractions from the inactive SLE patients either in autologous MLR or allogeneic MLR. When active SLE patients were studied, the Fc+ T cell fractions also responded abnormally in autologous MLR and allogeneic MLR. In addition, the Fc-T cells from the active SLE patients were not stimulated in the autologous MLR.
In summary, responding lymphocytes from SLE patients were defective, and this defect appeared to be most prominent when Fc+ T cells were used.
Relationship between Concanavalin A-Induced Suppressor T Cell Activity and Autologous MLR. Concanavalin A-induced suppressor T cell activity of patients with SLE were studied by a previously described procedure (5, 11) . Six patients with active SLE were studied simultaneously for suppressor T cell activity and autologous MLR. In every case, both suppressor cell generation and autologous MLR were markedly defective (Fig. 5) . Lymphocytes from six normal individuals studied at the same time demonstrated normal activity for both functions.
DISCUSSION
During the past few years, several investigators have observed that purified human T cells can proliferate in response to autologous non-T cells (6, 10, 12) . Although the nature of this reaction, called the autologous MLR, is uncertain, it has been proposed to be a mechanism by which T cells regulate B lymphocyte function (6, 13 autologous MLR in normal individuals is a T cell (6, 10) . However, there is a divergence of opinion concerning the precise nature of the stimulating cells. Although most investigators agree that, in general, a non-T cell is responsible, some investigators have ascribed most of the activity to L or K cells (6) , whereas others have claimed that SmIg-bearing B cells are the best stimulating cells (14) . Our (19, 20) . The animal studies support the hypothesis that autologous MLR may be an important correlate of cell interaction in normal immune responses (19, 20) . To explore further the defect in autologous MLR in patients with SLE, a number of additional studies were performed. We first examined the role of the stimulating non-T cells. Increasing the number of stimulating non-T cells did not correct the defect. The same SLE non-T cells that failed to stimulate in the autologous MLR were effective stimulating cells of an allogeneic MLR. However, this observation does not entirely eliminate the possibility that the defect is in the stimulating non-T cells, because the structures on these cells responsible for the allogeneic MLR may be separate from those capable of stimulating autologous MLR. Another possibility is that the defect in autologous MLR resides in the responding T cell population. To The defects of both autologous MLR and suppressor function observed in patients with SLE appear to be intimately related and may represent the same event.
